首页>
外国专利>
Prevention of Bone and Mineral Disorders by Restoring Calcium and Phosphate Homeostasis in Patients Suffering from Chronic Kidney Disease
Prevention of Bone and Mineral Disorders by Restoring Calcium and Phosphate Homeostasis in Patients Suffering from Chronic Kidney Disease
展开▼
机译:通过恢复慢性肾脏病患者的钙和磷酸盐稳态来预防骨和矿物质疾病
展开▼
页面导航
摘要
著录项
相似文献
摘要
The invention relates to the improvement in the control of calcium (Ca) or phosphate (Pi) homeostasis in a human subject who is suffering from chronic kidney disease (CKD) during any of stages 1 to 4 of CKD (as defined in National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(suppl 1):S1-S266.). Improvements in homeostasis will have multiple and numerous benefits to a patient suffering from CKD. The patient will benefit from the prevention of mineral and bone disorders and vascular calcification associated with CKD (the cardiovascular events are the leading causes of premature death in patients suffering from CKD). The improvement in the control of Ca and Pi homeostasis is achieved through the administration of parathyroid hormone (PTH) or a derivative to the patient
展开▼
机译:本发明涉及控制在慢性肾脏病(CKD)的第1-4阶段中任何一个阶段中患有慢性肾脏疾病(CKD)的人类受试者中钙(Ca)或磷酸盐(Pi)体内稳态的控制的改善(如国家肾脏基金会所定义) K / DOQI慢性肾脏病临床实践指南:评估,分类和分层。Am J Kidney Dis。2002; 39(suppl 1):S1-S266。)。稳态的改善将为患有CKD的患者带来多种益处。该患者将从预防与CKD相关的矿物质和骨骼疾病以及血管钙化中受益(心血管事件是CKD患者过早死亡的主要原因)。通过向患者施用甲状旁腺激素(PTH)或衍生物可改善对Ca和Pi稳态的控制
展开▼